Aquilo Capital Management, LLC Portfolio Holdings
Aquilo Capital Management, LLC
- $128 Million
- Q1 2024
Aquilo Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $128 Million distributed in 10 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arrowhead Pharmaceuticals, Inc. with a value of $26M, Regenxbio Inc. with a value of $19.1M, Blueprint Medicines Corp with a value of $17.3M, Arvinas, Inc. with a value of $16.8M, and Kymera Therapeutics, Inc. with a value of $15.6M.
Examining the 13F form we can see an decrease of $32.3M in the current position value, from $160M to 128M.
Aquilo Capital Management, LLC is based out at San Francisco, CA
Below you can find more details about Aquilo Capital Management, LLC portfolio as well as his latest detailed transactions.